For smaller spider veins, results from sclerotherapy can typically be seen within 3 to 6 weeks
Eli Lillys acquisition of Versanis Bio and integration of bimagrumab into its portfolio highlight its commitment to leading the market in innovative weight loss therapies
Clinical features, cardiovascular risk profile, and therapeutic trajectories of patients with type 2 diabetes candidate for oral semaglutide therapy in the Italian specialist care
The fight against tobacco, certainly in our lifetime, has been the great public health success
In Australia, data from 2023 describes 15 985 primary MBScompleted in the same year and the incidence of these procedures continues to rise in Australia [5, 6]
France offers a clear route for programs that align with established reimbursement and treatment pathways